We’d love to hear your feedback on this activity. It helps us to continually improve our products.
Cardinal Glennon Children’s Hospital, St. Louis, MO, USA
Elaine Siegfried is director of the Division of Pediatric Dermatology at the Cardinal Glennon Children’s Hospital, Saint Louis University Health Sciences Center, MO, USA. She is also the owner and director of Kids Dermatology, St. Louis, USA. read more
Dr Siegfried is a past president of the American Board of Dermatology, a founding member of the Pediatric Dermatology Research Alliance and chair of the Emerging Practice Models Committee at the American Academy of Dermatology. She is also a member or fellow of a number of other professional organizations, including the Society for Pediatric Dermatology and the American Dermatological Association. She has volunteered her services for many years as a member of scientific advisory boards for the National Eczema Association and the National Foundation for Ectodermal Dysplasia.
Dr Siegfried has authored approximately 130 journal papers and 20 book chapters, and served as principal investigator for more than 50 clinical trials.
Dr Elaine Siegfried discloses: Speaker Bureau fees from: Regeneron, Sanofi Genzyme and Verrica. Consulting fees from: AbbVie, Alphyn, ASLAN Pharmaceuticals, Boehringer Ingelheim, Cara Therapeutics, Incyte, Leo, NobelPharma, Novan, Novartis, Pfizer, Pierre Fabre, Regeneron, Sanofi Genzyme, UCB and Verrica. Contracted research: AI Therapeutics. Clinical trials (all fees to institution): Amgen, Janssen, Lilly, Pierre Fabre, Regeneron, Sanofi and Verrica. Data safety monitoring board: Espere Healthcare, Leo, Novan, Pfizer and UCB.Â
Children’s Hospital Zagreb, Croatia
Nives Pustišek is an assistant professor and head of the Department of Dermatology and Venereology, Gynecology and Reproductive Health at Children’s Hospital Zagreb, Croatia. read more
Dr PustiÅ¡ek is a renowned dermatologist and venereologist, and a specialist in the field of paediatric dermatology. She is particularly active in the areas of atopic dermatitis and psychodermatology, with a focus on improving the quality of life for patients and their families through educational programmes.Â
Dr Pustišek has published numerous articles in peer-reviewed medical journals and presented at international conferences.
Dr Nives Pustišek discloses: Speaker’s Bureau: AbbVie, Bayer, Bioderma, LEO Pharma, L’Oreal Adria, Novartis, Oktal Pharma, Pfizer and Sanofi-Aventis.
Ludwig-Maximilian University, Munich, Germany
Andreas Wollenberg is a professor of dermatology and allergy at the Ludwig-Maximilian University in Munich, Germany. He is also affiliated with the University Hospital Augsburg, Germany. read more
Prof. Wollenberg has conducted research in the field of atopic dermatitis, experimental dermatology, dendritic cell research, eczema herpeticum, perioral dermatitis and epidermal growth factor receptor inhibitor-induced skin toxicity. His research has generated more than 340 peer-reviewed publications.Â
Prof. Wollenberg is a member of the editorial board of the Journal of the European Academy of Dermatology and Venerology, and a reviewer for many biomedical journals. Prof. Wollenberg has served as head of the European Task Force on Atopic Dermatitis (ETFAD) for 10 years, and is the lead author of the ETFAD Position Paper on AD management. Moreover, he is the lead author of the current EuroGuiDerm Guidelines for Atopic Dermatitis. Prof. Wollenberg is an executive board member and secretary of the International Society of Atopic Dermatitis.
Prof. Andreas Wollenberg discloses: Advisory Board or Panel: AbbVie, Aileens, Almirall, Amgen, BMS, Galderma, Glenmark, GSK, Hans Karrer, Kyowa Kirin, Janssen, Leo Pharma, Eli Lilly, L’Oreal, MSD, Mylan, Novartis, Pfizer, Pierre Fabre, Regeneron, Sanofi-Aventis and UCB. Consultancy fees from: AbbVie, Aileens, Almirall, Amgen, Beiersdorf, Bioderma, Bioproject, BMS, Galderma, GSK, Hans Karrer, Kyowa Kirin, Janssen, Leo Pharma, Eli Lilly, L’Oreal, MSD, Mylan, Novartis, Pfizer, Pierre Fabre, Regeneron, Sandoz, Sanofi-Aventis and UCB. Grants/Research Support from: Leo Pharma (relationship terminated) and Pierre Fabre. Salary, Contractual Services from: Pierre Fabre. Speaker’s Bureau: AbbVie, Almirall, Amgen, Beiersdorf, Bioderma, Bioproject, BMS, Galderma, Glenmark, GSK, Hans Karrer, Kyowa Kirin, Janssen, Leo Pharma, Eli Lilly, L’Oreal, Maruho, MedImmune, MSD, Mylan, Novartis, Pfizer, Pierre Fabre, Regeneron, Sanofi-Aventis and UCB.